Kunstler on Pathocracy - >>> Memorial Service May 29,

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
184
Kunstler on Pathocracy -

>>> Memorial Service

May 29, 2023


https://kunstler.com/clusterfuck-nation/memorial-service/


“Liberalism was never about freedom, but nurtured a profound desire to change humanity above all other aspects. This rendered it a willing ally of tyrants promising to do the dirty work of such a project.” — John Waters on Substack


An anxious silence falls over the land this Memorial Day as we discern increasingly that those we put in charge of this shape-shifting thing called the public interest are running out of trips to lay on the people. Something grotesque is revealing itself: a bankruptcy not just of money but of national purpose, meaning, and legitimacy. Y ou realize this day, with a breaking heart, that your country has been stolen by psychopaths.

Brace for impact. We’re already off the road and now it’s only a matter of how this vehicle comes to a stop in the ditch. Then, it’s a question of how each of us emerges from the smoldering wreckage. The main thing, though, is clear to everyone: What we were riding in is no more. We’re out there stumbling around in the dark, in shock, trying desperately to assess our whereabouts and what has happened to us.

Now, the trouble with being ruled by psychopaths is that they don’t care about other people. They are actually incapable of imagining the lives of others, especially the fact that these others care about each other, and what happens to them. You may have noticed, for instance, that the psychopath Senator Lindsay Graham (R-SC) went to Ukraine last week and declared, “Russians are dying. We have never spent money so well.” Only a couple of months ago, he called for the assassination of Vladimir Putin. He stopped short of dissing Mr. Putin’s mother.

Ukraine, of course, is a lost cause, and it was never a good cause in the first place. Contrary to Lindsay Graham’s untoward utterance, American money has killed far more Ukrainians than Russians. He overlooked that because he doesn’t care about the Ukrainians, for whose sake our “folks” in charge supposedly undertook this clusterfuck. Lindsay Graham also may not have noticed that our country is collapsing and Russia is not. That’s must be because Lindsay Graham does not care about Americans, either.

As for our money, it looks like most of the rest of the world — the nations that still produce things of value — are so turned-off by American pathocracy that they are seeking every way possible to stop using our money in international trade settlements. That money, our dollar, became the world’s reserve currency because our country ended up on top in the previous world war and for the better part of a century afterward dominated the planet militarily. Naturally, as our leadership turned more pathological and pathocratic, so did our military endeavors — until lately they amount to little more than just smashing up other countries to show we can do it.

These other countries must wonder which is the next place that America will try to smash up? Two of these other countries, Russia and China, are coming around to the realization that they are possibly better equipped to do the smashing than America is. There is no indication that our pathocracy recognizes that the next smash-up may be World War Three, and that we may not emerge from it victorious.

Hence, our anxiety this Memorial Day as we reflect on America’s military exploits generally, and must perforce contemplate our less-than-glorious prospects ahead. How will our pathocrat neo-con strategists greet the debacle of our failure in Ukraine? Will they dream up yet another misadventure as reckless and absurd? You have good reason to be concerned.

Pathocracy always marches toward totalitarianism because pathocrats can’t imagine a management of public affairs by a people who care about each other (and their country). Therefore, everyone must be subject to incessant coercion and punishment, especially for their thoughts (and especially for thoughts of opposition to pathocracy). However, there are certainly more people who care about each other than there are psychopaths in America. I’m not a big fan of quantification but, for the record, psychiatric meta-analysis estimates that 1.2 to 4.5 percent of the population displays psychopathic personality disorders.

How that tiny fraction of the citizenry came to take charge of our affairs is surely the big mystery of the moment. My guess is that under conditions of economic-social-and-political collapse, the people who care about each other become preoccupied with their mutual caretaking duties while the psychopaths, unburdened by such cares, can go about other business — such as plunder, murder, and the sowing of chaos.

Sometimes in history, the pathocrats are simply overthrown by the majority of humans with functioning emotional equipment. It’s not easy, though, because in most other places around the world, the pathocracy become the sole owners of the guns and have armies and police at their disposal to put down revolts. That’s not quite exactly the case here in the USA with our Second Amendment to the Constitution. The putative president, “Joe Biden,” cracked some time ago that anyone seeking to oppose him better bring some F-15 fighter planes to get the job done. As the good book says: Pride goeth before destruction, and a haughty spirit before a fall.”

This Memorial Day is the pregnant moment before history gives birth to new and astounding events. Everyone senses it. The rough beasts are out there slouching across the fruited plain. Attend to your duties courageously, as those before us did, who we remember today.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Thor Equities Sells Amazon Distribution Center for $157M

Updated Category News Views 191

Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...

Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand

Updated Category News Views 169

Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...

Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth

Updated Category News Views 341

Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....

Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights

Updated Category News Views 175

Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....

Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation

Updated Category News Views 181

Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...

Continue Reading